-
1Dissertation/ Thesis
Authors: Rôxo, Alana Almeida
Contributors: Ramos, Helton Estrela, orcid:0000-0002-2900-2099, http://lattes.cnpq.br/5624505454133902, Sardinha, Mariluze Maria de Souza, http://lattes.cnpq.br/0990732888878696, Castelo Branco, Bruno, orcid:0009-0001-3667-167X, http://lattes.cnpq.br/8913177316699431, Cury, Adriano Namo, orcid:0000-0002-9777-8366, http://lattes.cnpq.br/7133785713614688
Subject Terms: Oftalmopatia associada à tireoide, Oftalmopatia de Graves, Doença Ocular da Tireoide (DOT), Doença do olho seco, Síndromes do Olho Seco, Doença da superfície ocular, Thyroid-associated ophthalmopathy, Graves Ophthalmopathy, Thyroid eye disease, Dry Eye Syndromes, Ocular surface disease, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::OFTALMOLOGIA, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA
File Description: application/pdf
Relation: 1. WIERSINGA, W.M.; BARTALENA, L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid, [s.l], v.12, n.10, p.855-860, 2012. DOI:10.1089/105072502761016476. 2. SMITH, T.J.; HEGEDUS, L. Grave’s disease. N. Engl. J. Med., Boston, v.375, n.16, p.1552–1565, 2016. 3. BARTALENA, L. et al. EUGOGO, The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur. J. Endocrinol., Oslo, v.185, n.4, p. G43–G67, 2021. DOI: https://doi.org/10.1530/EJE-21-0479. 4. HE, C. Z. et al. Autologous serum eye drops for patients with dry eye disease: a systematic review and meta-analysis of randomized controlled trials. Front. Med., Lausanne, v.11, p. 1430785, 2024. DOI:10.3389/fmed.2024.1430785. 5. SHEPPARD, J.; SHEN LEE, B.; PERIMAN, L. M. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann. Med., London, v.55, p.241–252, 2023. DOI:10.1080/07853890.2022.2157477. 6. BRON, A. J. et al. TFOS DEWS II pathophysiology report. Ocul. Surf., United States, v.15, p.438–510, 2017. DOI:10.1016/j.jtos.2017.05.011. 7. GILBARD, J.P.; FARRIS, R. L. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol., Oxford, v. 61, n.1, p.108–116, 1983. 8. KHURANA, A. K, et al. Tear film profile in Graves’ophthalmopathy. Acta Ophthalmol., Oxford, v.70, n.3, p. 346–349, 1992. 9. DEWS. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul. Surf., United States, v.5, n.2, p.75–92, 2007. DOI:10.1016/s1542-0124(12)70081-2. 10. ISMAILOVA, D.S.; FEDOROV, A.A.; GRUSHA, Y.O. Ocular surface changes in thyroid eye disease. Orbit, [s.l], v.32, n.2, p.87–90, 2013. 11. MAK, F.H.W.; TING, M.; EDMUNDS, M. R. Videographic Anaylsis of Blink Dynamics following upper eyelid blepharoplasty patients. Plast. Reconstr. Glob Open, United Sates, v.8, n.7, p.e 2991, 2020. DOI:10.1097/GOX.0000000000002991. 12. TAKAHASHI, Y, et al. Tear film break-up patterns in thyroid eye disease. Sci. Rep., London, v.11, n.1, p.5288, 2021. DOI:10.1038/s41598-021-84661-4. 74 13. BRUSCOLINI, A. et al. Dry Eye Syndrome in Non-Exophthalmic Graves Disease. Semin Ophthalmol., United States, v.30, n.5-6, p.372–376, 2015. DOI:10.3109/08820538.2013.874491. 14. CRAIG, J.P. et al. TFOS DEWS II Definition and Classification Report. Ocul. Surf., United States, v.15, n.3, p.276–283, 2017. 15. DOUGLAS, R.S.; GUPTA, S. The pathophysiology of thyroid eye disease: Implications for immunotherapy. Curr Opin Ophthalmol., [s.l], v.22, n.5, p. 385–390, 2011. DOI:10.1097/ICU.0b013e3283499446. 16. PATEL, A.; YANG, H.; DOUGLAS, R. S. A New Era in the Treatment of Thyroid Eye Disease. Am. J. Ophthalmol., Chicago, v.208, p. 281–288, 2019. DOI:10.1016/j.ajo.2019.07.021. 17. JENNIFER, P. et al. TFOS DEWS II Definition and Classification Report. Ocular Surf., United States, v.15, n. 3, p. 276-283, 2017. DOI: https://doi.org/10.1016/j.jtos.2017.05.008. 18. PAPAS, E. B. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol. Opt., United Kingdom, v.41, p.1254–1266, 2021. DOI:10.1111/opo.12888. 19. BOBORIDIS, K. G. et al. Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey. BMJ Open., London, v.13, p. e067007, 2023. DOI:10.1136/bmjopen-2022-067007. 20. Ayaki M, et al. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. Sci. Rep., London, v.6, p.22480, 2016. DOI:10.1038/srep22480. 21. DEO, N.; NAGRALE, P. Dry eye disease: an overview of its risk factors, diagnosis, and prevalence by age, sex, and race. Cureus, United States, v.16, n.2, p.e54028, 2024. DOI:10.7759/cureus.54028. 22. PARK, J.; BAEK, S. Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss. Acta Ophthalmol., Oxford, v. 97, n.5, p. e800–806, 2019. DOI:10.1111/aos.14000. 23. BRUSCOLINI A, et al. Dry eye syndrome in non-exophthalmic graves’ disease. Semin Ophthalmol., [s.l], v.30, n.5–6, p. 372–376, 2015. DOI:10.3109/ 08820538.2013.874491. 24. ACHTSIDIS, V. et al. Clinical disease of tear film, diagnosis and management. Eur. Ophthalmic. Rev., [s.l.], v.8, n.1, p.17, 2014. 25. STERN, M. E. et al. A unified theory of the role of the ocular surface in dry eye. Adv. Exp. Med. Biol., New York, v.438, p. 643–651, 1998. 75 26. CHER, I. Ocular surface concepts: Development and citation. Ocul. Surf., United States, v.12, p. 10–13, 2014. DOI:10.1016/j.jtos.2013.10.004. 27. TUTT, R. et al. Optical and visual impact of tear break-up in human eyes. Invest. Ophthalmol. Vis. Sci., United States, v.41, n.13, p.4117–4123, 2000. 28. ROLANDO, M.; ZIERHUT M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv. Ophthalmol., [s.l], v.45, supl. 2, p.S203–210, 2001. 29. ZHOU, L. et al. Proteomic analysis of rabbit tear fluid: Defensin levels after an experimental corneal wound are correlated to wound closure. Proteomics, [s.l.], v.7, n.17, p. 3194–3206, 2007. DOI:10.1002/pmic.200700137. 30. ZHOU, L. et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J. Proteome Res. United States, v.3, n.3, p.410–416, 2004. DOI:10.1021/pr034065n. 31. ZHOU, L. et al. In-depth analysis of the human tear proteome. J. Proteomics, [s.l], v.75, n.13, p. 3877–3885, 2012. DOI:10.1016/j.jprot.2012.04.053. 32. GREEN-CHURCH, K.B. et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest. Ophthalmol. Vis. Sci., United States, v.52, n.4, p.1979– 1993, 2011. DOI:10.1167/iovs.10-6997d. 33. KNOP, E. et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest. Ophthalmol. Vis. Sci., United States, v.52, p.1938–1978, 2011. 34. DEN, S. et al. Association between meibomian gland changes and aging, sex, or tear function. Cornea, [s.l.], v.25, n.6, p. 651–655, 2006. DOI:10.1097/01.ico.0000227889.11500.6f. 35. ALGHAMDI, Y. A, et al. Epidemiology of Meibomian Gland Dysfunction in an Elderly Population. Cornea, [s.l], v.35, n.6, p. 731–735, 2016. DOI:10.1097/ICO.0000000000000815. 36. HYKIN, P.G.; BRON, A. J. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea, [s.l], v.11, p.334–3342, 1992. 37. OBATA H. Anatomy and histopathology of human meibomian gland. Cornea, [s.l.], v.21, supl. 7, p.S70–S74, 2002. DOI:10.1097/01.ico.0000263122.45898.09. 38. ROBIN, J.B. et al. In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. Ophthalmology. [s.l.], v.92, n.10, p.1423–1426, 1985. DOI:10.1016/s0161-6420(85)33848-4. 76 39. GUTGESELL, V.J.; STERN, G.A.; HOOD, C. I. Histopathology of meibomian gland dysfunction. Am. J. Ophthalmol., Chicago, v.94, n.3, p.383–387, 1982. DOI:10.1016/0002-9394(82)90365-8. 40. HOM, M.M. et al. Prevalence of meibomian gland dysfunction. Optom. Vis. Sci., United States, v.67, p.710–712, 1990. 41. MATHERS, W.D. et al. Meibomian gland dysfunction in chronic blepharitis. Cornea, [s.l], v.10, n.4, p.277–285, 1991. DOI:10.1097/00003226-199107000-00001. 42. WEI, A. et al. Evaluation of age-related changes in human palpebral conjunctiva and meibomian glands by in vivo confocal microscopy. Cornea, [s.l], v.30, n.9, p.1007– 1012, 2011. DOI:10.1097/ICO.0b013e31820ca468. 43. Van SETTEN, G. B. Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered. Int. J. Mol. Sci., Switzerland, v.21, n.12, p.4333, 2020. doi:10.3390/ijms21124333. 44. LEE, O.L. et al. Evaluation of the corneal epithelium in non-Sjögren’s and Sjögren’s dry eyes: an in vivo confocal microscopy study using HRT III RCM. BMC Ophthalmol., [s.l], v.18, p.309, 2018. DOI:10.1186/s12886-018-0971-3. 45. HODGES, R.R.; DARTT, D. A. Signaling Pathways of Purinergic Receptors and Their Interactions with Cholinergic and Adrenergic Pathways in the Lacrimal Gland. J. Ocul. Pharmacol. Ther., United States, v.32, p.490-497, 2016. 46. HARRIS, M.A. et al. CT dimensions of the lacrimal gland in Graves orbitopathy. Ophthal Plast Reconstr Surg., [s.l.], v.28, p.69–72, 2012. DOI:10.1097/IOP.0b013e31823c4a3a. 47. ECKSTEIN, A.K. et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand., [s.l], v.82, n.3, p.291–297, 2004. DOI:10.1111/j.1395-3907.2004.00268.x. 48. HUH, H. D. et al. The change of lacrimal gland volume in Korean patients with thyroidassociated ophthalmopathy. Korean J. Ophthalmol., Bethesda, v.30, n.5, p.319–325, 2016. DOI:10.3341/kjo.2016.30.5.319. 49. HUANG, D.P. et al. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy. Invest. Ophthalmol. Vis. Sci., United States, v.55, n.8, p.4935–4943, 2014. DOI:10.1167/iovs.13-13704. 50. ZOUKHRI, D. Effect of inflammation on lacrimal gland function. Exp. Eye Res., [s.l], v.82, n.5, p.885–898, 2006. DOI:10.1016/j.exer.2005.10.018. 77 51. MATHEIS, N. et al. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid, [s.l.], v.22, p.1039–1045, 2012. 52. KHALIL, H.A. et al. Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy. Doc. Ophthalmol., [s.l], v.72, n.3-4, p.329–334, 1989. DOI:10.1007/BF00153500. 53. MANTELLI, F.; MAURIS, J.; ARGUESO, P. The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases. Curr. Opin. Allergy Clin. Immunol., United States, v.13, n.5, 563–8, 2013. DOI:10.1097/ACI.0b013e3283645899. 54. MANTELLI, F.; ARGUESO, P. Functions of ocular surface mucins in health and disease. Curr. Opin. Allergy Clin. Immunol., United States, v.8, n.5, ´p.477–483, 2008. DOI:10.1097/ACI.0b013e32830e6b04. 55. UCHINO, Y. The Ocular Surface Glycocalyx and its Alteration in Dry Eye Disease: A Review. Invest. Ophthalmol. Vis. Sci., United States, v.59, n.14, p.DES157–DES62, 2018. DOI:10.1167/iovs.17-23756. 56. SWAMYNATHAN, S.K.; WELLS, A. Conjunctival goblet cells: Ocular surface functions, disorders that affect them, and the potential for their regeneration. Ocul. Surf., United States, v.18, p.19–26, 2020. 57. UCHINO Y, et al. Alteration of galectin-3 in tears of patients with dry eye disease. Am. J. Ophthalmol., Chicago, v.159, n.6, p. 1027–1035, 2015. DOI:10.1016/j.ajo.2015.02.008. 58. LEONG, Y.Y.; TONG, L. Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul. Surf., United States, v.13, n.2, p.103–109, 2015. DOI:10.1016/j.jtos.2014.10.003. 59. ZHANG, X. et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One, United States, v.7, n.5, p. e36822, 2012. DOI:10.1371/journal.pone.0036822. 60. BOSE, T. et al. Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease. Sci. Rep., London, v.7, p. 45312, 2017. 61. WILLIAMS, G.P. et al. The dominant human conjunctival epithelial CD8alphabeta+ T cell population is maintained with age but the number of CD4+ T cells increases. Age, Dordrecht, v.34, n.6, p.1517–1528, 2012. DOI:10.1007/s11357-011-9316-3. 62. KABOSOVA, A. et al. Compositional differences between infant and adult human corneal basement membranes. Invest. Ophthalmol Vis. Sci., United States, v.48, n.11, p. 4989–4999, 2007. DOI:10.1167/iovs.07-0654. 78 63. KRUEGEL, J.; MIOSGE, N. Basement membrane components are key players in specialized extracellular matrices. Cell Mol. Life Sci., [s.l], v.67, n.17, p. 2879–2895, 2010. DOI:10.1007/s00018-010-0367-x. 64. WILSON, S.E.; TORRICELLI, A.A.M.; MARINO, G. K. Corneal epithelial basement membrane: Structure, function and regeneration. Exp. Eye Res., United States, v.194, p. 108002, 2020. DOI:10.1016/j.exer.2020.108002. 65. ALLANSMITH, M.R.; GREINER, J.V.; BAIRD, R. S. Number of inflammatory cells in the normal conjunctiva. Am. J. Ophthalmol., Chicago, v.86, n.2, p.250–259, 1978. DOI:10.1016/s0002-9394(14)76821-7. 66. SHAN, M. et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science, [s.l], v.342, n.6157, p.447–453, 2013. DOI:10.1126/science.1237910. 67. RALPH, R. A. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest. Ophthalmol., St. Louis, v.14, n.4, p. 299–302, 1975. 68. MURUBE, J.; RIVAS, L. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity. Eur. J. Ophthalmol., United States, v.13, p. 115–127, 2003. 69. PFLUGFELDER, S.C. et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology, [s.l], v.104, n.2, p. 223–235, 1997. DOI:10.1016/s0161- 6420(97)30330-3. 70. KNOP, N.; KNOP, E. Conjunctiva-associated lymphoid tissue in the human eye. Invest. Ophthalmol Vis. Sci., United States, v.41, p.1270–1279, 2000. 71. CERUTTI, A.; CHEN, K.; CHORNY, A. Immunoglobulin Responses at the Mucosal Interface. Annu Rev. Immunol., United States, v. 29, p.273–293, 2011. DOI:10.1146/annurev-immunol-031210-101317. 72. BOSCHI, A. et al. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J. Ophthalmol., v.89, n.6, p. 724, 2005. DOI:10.1136/bjo.2004.050807. 73. ZHANG, L. et al. Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes. Invest. Ophthalmol. Vis. Sci., United States, v.47, p.5197– 5203, 2006. DOI: https://doi.org/10.1167/iovs.06-0596. 74. HUANG, D.P. et al. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch. Clin. Exp. Ophthalmol., Berlin, v.250, n.4, p. 619– 625, 2012. DOI:10.1007/s00417-011-1863-x. 79 75. KASHKOULI, M.B. et al. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease. Ocul. Surf., United States, v.16, n.4, p.458–462, 2018. DOI:10.1016/j.jtos.2018.07.003. 76. TSUI. S. et al. Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease. J. Immunol., Netherlands, v.181, n.6, p.4397–4405, 2008. DOI: https://doi.org/10.4049/jimmunol.181.6.4397 77. KRIEGER, C. C. et al. Thyroid stimulating hormone (TSH)/insulin-like growth factor 1 (IGF1) receptor cross-talk in Human cells. Curr. Opin. Endocr. Metab. Res., United Kingdom, v.2, p.29–33, 2018. DOI: https://doi.org/10.1016/j.coemr.2018.01.007 78. GREWAL, I.S.; FLAVELL, R. A. The Role of CD40 Ligand in Costimulation and TCell Activation. Immunological Rev., Copenhagen, v.153, p.85–106, 1996. DOI: https://doi.org/10.1111/j.1600-065X.1996.tb00921.x. 79. FELDON, S.E. et al. Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves’ Ophthalmopathy. Investig. Ophthalmol. Vis. Sci., United States, v.46, p. 3913–3921, 2005. DOI: https://doi.org/10.1167/iovs.05-0605. 80. SEMPOWSKI, G.D. et al. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am. J. Physiol. Cell Physiol., United States, v.274, n.3, p.C707-C714, 1998. DOI: https://www.ncbi.nlm.nih.gov/pubmed/29591126. 81. WANG, H.S. et al. Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation. J. Biol. Chem., [s.l], v.271, n.37, p. 22718–22728, 1996. DOI: https://doi.org/10.1074/jbc.271.37.22718 82. TOKER, E.; ASFUROĞLU, E. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Cornea, [s.l], v.29, n.2, p.133–140, 2010. DOI:10.1097/ICO.0b013e3181acf68d. 83. KUMAR, S. et al. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves’ ophthalmopathy. J. Mol. Endocrinol., Bristol, v.46, n. 3, p.155–163, 2011. DOI: https://doi.org/10.1530/JME-11-0006. 84. PRITCHARD, J. et al. Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway. J Immunol., Inglaterra, v.170, n.12, p.6348-6354, 2003. DOI: https://doi.org/10.4049/jimmunol.170.12.6348 80 85. DOUGLAS, R.S. et al. B Cells from Patients with Graves’ Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis. J. Immunol., Inglaterra, v.181, n.8, p.5768–5674, 2008. DOI: https://doi.org/10.4049/jimmunol.181.8.5768 86. DOUGLAS, R.S. et al. Aberrant Expression of the Insulin-Like Growth Factor-1 Receptor by T Cells from Patients with Graves’ Disease May Carry Functional Consequences for Disease Pathogenesis. J Immunol., Inglaterra, v.178, n.5, p. 3281– 3287, 2007. DOI: https://doi.org/10.4049/jimmunol.178.5.3281. 87. SMITH, T.J.; HOA, N. Immunoglobulins from Patients with Graves’ Disease Induce Hyaluronan Synthesis in Their Orbital Fibroblasts through the Self-Antigen, InsulinLike Growth Factor-I Receptor. J. Clin. Endocrinol. Metab., United States, v.89, n.10, p.5076–5080, 2004. DOI: https://doi.org/10.1210/jc.2004-0716 88. SMITH, T.J.; JANSSEN, J.A.M.J.L. Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy. Endocr. Rev., United States, v.40, p.236–267, 2019. DOI: https://doi.org/10.1210/er.2018-00066 89. BARTALENA, L. et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol., Oslo, v.158, n.3, p. 273–285, 2008. DOI: https://doi.org/10.1530/EJE-07-0666. 90. BARTALENA, L. et al. Orbitopathy Guidelines for the Management of Graves’ Orbitopathy. Eur. Thyroid J., Switzerland, v.5, p.9–26, 2016. DOI: https://doi. org/10.1159/000443828. 91. BARTALENA L, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol., Oslo, v.158, n.3, p.273–285, 2008. DOI: https://doi.org/10.1530/EJE-07-0666. 92. RUNDLE, F. Management of exophthalmos and related ocular changes in Graves’ disease. Metabolism, [s.l], v.6, n.1, p.36–48, 1957. 93. MOURITS, M.P. et al. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br. J. Ophthalmol., United States, 1989;73(8):639–44. doi: https://doi.org/10.1136/ bjo.73.8.639 94. VILLANI, E. et al. Corneal involvement in Graves' orbitopathy: an in vivo confocal study. Investig. Ophthalmol. Vis. Sci., United States, v.51, n.9, p.4574–4578, 2010. DOI:10.1167/iovs.10-5380. 95. WU, L-Q. et al. Altered Corneal nerves in chinese thyroid-associated ophthalmopathy patients observed by in vivo con- focal microscopy. Med. Sci. Monit., United States, v.25, p.1024–1031, 2019. DOI:10.12659/MSM.912310. 81 96. KISHAZI, E. et al. Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy. Sci. Rep., Reino Unido, v.8, n.1, p.10792, 2018. DOI:10.1038/s41598-018-29113-2. 97. UJHELYI, B. et al. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid, [s.l], v. 22, n.4, p. 407–414, 2012. DOI:10.1089/thy.2011.0248. 98. CHEN, Q. The expression of interleukin-15 and interleukin-17 in tears and orbital tissues of Graves ophthalmopathy patients. J. Cell Biochem., Unique, v.120, n.4, p.6299–6303, 2019. DOI:10.1002/jcb.27916. 99. CAI, K.B.; WEI, R. L. Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy. Endocrine, [s.l.], v.44, n.1, p.140–144, 2013. DOI:10.1007/s12020-012-9840-7. 100. SONG, R. H. et al. Proteomics screening of differentially expressed cytokines in tears of patients with Graves' ophthalmopathy. Endocr. Metab. Immune Disord. Drug Targets, United Arab Emirates, v.20, n.1, p.87–95, 2020. DOI:10.2174/1871530319666190618142215. 101. MATHEIS N, et al. Proteomics differentiate between thyroid-associated orbitopathy and dry eye syndrome. Invest. Ophthalmol. Vis. Sci., United States, v.56, n.4, p. 2649– 2656, 2015. DOI:10.1167/iovs.15-16699. 102. AASS, C. et al. Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy. PLoS One., United States, v.12, n.4, p. e0175274, 2017. DOI:10.1371/journal.pone.0175274. 103. CHOI, W. et al. Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score. BMC Ophthalmol., [s.l], v.18, n.1, p.303, 2018. DOI:10.1186/s12886-018-0969-x. 104. WEI, Y-H, et al. In vivo confocal microscopy of bulbar conjunctiva in patients with Graves’ ophthalmopathy. J. Formos Med. Assoc., China, v.114, n.10, p.965–972, 2015. 105. XU N, et al. Ocular surface characteristics and impression cytology in patients with active versus inactive Thyroid Eye Disease. Eye Sci., v.27, n.2, p.64–68, 2012. DOI:10.3969/j.issn.1000-4432.2012.02.003. 106. DU, B. et al. Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases. Eye, London, v.35, n.8, p.2294–2301, 2021. DOI:10.1038/s41433-020-01246-7. 107. ALVES, M. et al. Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS One, United States, v.9, n.5, p. e97921, 2014. DOI:10.1371/journal.pone.0097921. 82 108. SINGH, S. et al. Lacrimal and meibomian gland evaluation in dry eye disease: A mini review. Indian J. Ophthalmol., India, v.71, n.4, p.1090-1098, 2023. 109. SALL, K. et al. Validação de uma escala de classificação modificada do National Eye Institute para coloração de fluoresceína da córnea. Clin. Ophthalmol., Australia, v.17, p.757-767, 2023. DOI: https://doi.org/10.2147/OPTH.S398843 110. KIM, H.C.; PARK, W. H. Propriedade fluorescente do conjugado glicol quitosanafluoresceína isotiocianato para material de bioimagem. Int. J. Biol. Macromol., Netherlands, v.135, p.1217-1221, 2019. 111. ISMAILOVA, D.S.; FEDOROV, A.A.; GRUSHA, Y. O. Ocular surface changes in thyroid eye disease. Orbit., [s.l], v.32, n.2, p. 87–90, 2013. DOI:10.3109/01676830.2013.764440. 112. McGINNIGLE, S.; NAROO, S.A.; EPERJESI, F. Evaluation of dry eye. Surv. Ophthalmol., United States, v.57, n.4, p.293–316, 2012. DOI:10.1016/j.survophthal.2011.11.003. 113. BRON, A. J. et al. Clinical staining of the ocular surface: Mechanisms and interpretations. Prog. Retin. Eye Res., v. 44, p.36-61, 2015. DOI: https://doi.org/10.1016/j.preteyeres.2014.10.001. 114. HOLLY, F.J.; LAMBERTS, D.W.; ESQUIVEL, E. D. Cinética do fluxo capilar lacrimal na tira de Schirmer. Curr. Eye Res., London, v.2, n.1, p.57-70, 1982. 115. EKICI, E.; CAGLAR, C.; AKGÜMÜŞ, E. Ü. A repetibilidade, reprodutibilidade e correlação do teste de Schirmer: uma comparação entre olhos abertos e fechados. Korean J. Ophthalmol., Korea, v.36, n. 4, p.306-312, 2022. 116. KORB, D. R. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea, [s.l], v.19, n.4, p.483-486, 2000. DOI:10.1097/00003226-200007000-00016. 117. SCHIFFMAN, R.M. et al. Reliability and Validity of the Ocular Surface Disease Index. Arch. Ophthalmol., v.118, n.5, p. 615–621, 2000. DOI:10.1001/archopht.118.5.615 118. PRIGOL, A. M. et al. [Translation and validation of ocular surface disease index to Portuguese]. Arq. Bras. Oftalmol., São Paulo, v.75, n.1, p. 24–28, 2012. DOI:10.1590/S0004-27492012000100005 119. ALLAM, I. Y. et al. Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study. Clin. Ophthalmol., New Zealand, v.15, p. 2481-2488, 2021. DOI:10.2147/OPTH.S317708. 83 120. GUPTA, A.; SADEGHI, P.B.; AKPEK, E.K. Occult thyroid eye disease in patients presenting with dry eye symptoms. Am. J. Ophthalmol., United States, v.147, n.5, p.919–923, 2009. DOI:10.1016/j.ajo.2008.12.007. 121. XU, N. et al. Ocular surface characteristics and impression cytology in patients with active versus inactive Thyroid Eye Disease. Eye Sci., China, v.2, n.2, p.64–68, 2012. DOI:10.3969/j.issn.1000-4432.2012.02.003. 122. WANG, C-Y, et al. The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study. BMC Ophthalmol., [s.l], v.18, n.1, p.90, 2018. DOI:10.1186/s12886-018-0763-9. 123. KIM, Y. S et al. Meibomian gland dysfunction in Graves’ orbitopathy. Can. J. Ophthalmol., Montreal, v.50, n. 4, p.278–282, 2015. DOI:10.1016/j.jcjo.2015.05.012.; https://repositorio.ufba.br/handle/ri/43031
Availability: https://repositorio.ufba.br/handle/ri/43031
-
2Dissertation/ Thesis
Authors: Esperidião, Ana Carolina Duarte
Contributors: Rodrigues, Ricardo, http://lattes.cnpq.br/0132446377322877, Silva, Robinson Sabino da, http://lattes.cnpq.br/1886483839073466, Zezell, Denise Maria, http://lattes.cnpq.br/3524890504250775, Silva, Sindeval José da, http://lattes.cnpq.br/7291894930505297
Subject Terms: Ciências médicas, câncer de tireoide, nódulo tireoidiano, tecido tireoidiano, Espectroscopia no Infravermelho por Transformada de Fourier acoplado com o acessório de Reflexão Total Atenuada, espectroscopia infravermelha, algoritmos de aprendizado de máquina, thyroid cancer, thyroid nodule, thyroid tissue, Attenuated Totl Reflection-Fourier Transform Infrared, infrared spectroscopy, machine learning algorithms, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, Corpo carotídeo, Glândula tireóide - Câncer, Espectroscopia de infravermelho, ODS::ODS 3. Saúde e bem-estar - Assegurar uma vida saudável e promover o bem-estar para todos, em todas as idades
File Description: application/pdf
Relation: https://repositorio.ufu.br/handle/123456789/45135; http://doi.org/10.14393/ufu.di.2025.5062
-
3Dissertation/ Thesis
Authors: SOUZA, Adriane Fonseca de
Contributors: GOMES, Daniela Lopes, http://lattes.cnpq.br/0014255351015569
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Alimentação, Determinante de saúde, Diabetes do tipo 2, Type 2 diabetes, Food, Health determinant, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17173
-
4Dissertation/ Thesis
Authors: TOMPSON, Amanda Cristina Cunha
Contributors: GOMES, Daniela Lopes, http://lattes.cnpq.br/0014255351015569
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus tipo 1, Covid-19, Acompanhamento nutricional, Teleconsulta, Nutritional monitoring, Teleconsultation, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17187
-
5Dissertation/ Thesis
Authors: LOBATO, Alyne Maciel
Contributors: SOUZA, Ana Carolina Contente Braga de, http://lattes.cnpq.br/0609863332556837
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus tipo 2, Idosos, Autocuidado, Tecnologia assistiva, Type 2 diabetes mellitus, Elderly, Self-care, Assistive technology, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17174
-
6Dissertation/ Thesis
Authors: NORONHA, Hirley Gabriel Reimão
Contributors: SANTOS, Ândrea Kely Campos Ribeiro dos, http://lattes.cnpq.br/3899534338451625, orcid:0000-0001-7001-1483
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus, Insulinoterapia, Análogos de insulina, Insulin therapy, Insulin analogues, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17172
-
7Dissertation/ Thesis
Authors: GOMES, Lorena Regina Velasco Silva
Contributors: SOUZA, Ana Carolina Contente Braga de, http://lattes.cnpq.br/0609863332556837
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes tipo 1, Colecalciferol, Doença renal do diabetes, Type 1 diabetes, Cholecalciferol, Diabetic kidney disease, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17148
-
8Dissertation/ Thesis
Authors: PALHETA, Rayelly Cíntia Ataíde
Contributors: FELÍCIO, João Soares, http://lattes.cnpq.br/8482132737976863, GOMES, Daniela Lopes, http://lattes.cnpq.br/0014255351015569
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus, Nutrição, Rapid review, Nutrition, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17140
-
9Dissertation/ Thesis
Authors: SOUSA, Juliana Ferreira de
Contributors: SANTOS, Marcia Costa dos, http://lattes.cnpq.br/5450061620179886
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Retinopatia diabética, Rastreamento, Protocolo clínico, Diabetic retinopathy, Tracking, Clinical protocol, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17130
-
10Dissertation/ Thesis
Authors: SILVA, Marcelina Ribeiro da
Contributors: QUEIROZ, Natércia Neves Marques, http://lattes.cnpq.br/5359261920325026
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Tecnologia educacional, Diabetes mellitus, Pé diabético, Educational technology, Diabetic foot, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17139
-
11Dissertation/ Thesis
Authors: TEIXEIRA, Marcela Rassy
Contributors: GOMES, Daniela Lopes, http://lattes.cnpq.br/0014255351015569
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Protocolo nutricional, Diabetes melitus tipo 1, Terapia nutricional, Nutritional protocol, Type 1 diabetes mellitus, Nutritional therapy, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17138
-
12Dissertation/ Thesis
Authors: SILVA, Ariel Regina Silva da
Contributors: SOUZA, Ana Carolina Contente Braga de, http://lattes.cnpq.br/0609863332556837
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus, Classificação de diabetes, Diagnóstico de diabetes, Protocolo, Diabetes classification, Diabetes diagnosis, Protocol, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17128
-
13Dissertation/ Thesis
Contributors: GOMES, Daniela Lopes, http://lattes.cnpq.br/0014255351015569
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Covid-19, Distanciamento social, Saúde mental, Hábitos alimentares, Diabetes mellitus tipo 1, Social distancing, Type 1 diabetes mellitus, Mental health, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17147
-
14Dissertation/ Thesis
Authors: PALÁCIOS, Amanda de Oliveira Góes
Contributors: FELÍCIO, João Soares, http://lattes.cnpq.br/8482132737976863
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus, Dislipidemias, Hipertrigliceridemia, Hipercolesterolemia, Risco cardiovascular, Dyslipidemias, Hypertriglyceridemia, Cardiovascular risk, Hypercholesterolemia, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17127
-
15Dissertation/ Thesis
Authors: SANTOS, Grace Kelly Cabral dos
Contributors: PIANI, Pedro Paulo Freire, http://lattes.cnpq.br/6434100473666705
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Abordagem multiprofissional, Atenção a saúde, Diabetes mellitus (DM), Multiprofessional approach, Health care, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17129
-
16Dissertation/ Thesis
Contributors: FELÍCIO, Karem Mileo, http://lattes.cnpq.br/5289063715182942, GOMES, Daniela Lopes, http://lattes.cnpq.br/0014255351015569
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes Mellitus, Controle glicêmico, Educação em saúde, Glycemic control, Health education, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17146
-
17Dissertation/ Thesis
Authors: JANAÚ, Luísa Corrêa
Contributors: FELÍCIO, João Soares, http://lattes.cnpq.br/8482132737976863, QUEIROZ, Natércia Neves Marques de, http://lattes.cnpq.br/5359261920325026
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Tratamento farmacológico, Diabetes Mellitus tipo 2, Controle glicêmico, Pharmacological treatment, Type 2 Diabetes Mellitus, Glycemic control, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17115
-
18Dissertation/ Thesis
Authors: SOUZA, Larissa Mayane Reis Barros de
Contributors: SOUZA, Ana Carolina Contente Braga de, http://lattes.cnpq.br/0609863332556837
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus gestacional, Rastreio, Diagnóstico, Gestational diabetes mellitus, Diagnosis, Screening, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17134
-
19Dissertation/ Thesis
Authors: OLIVEIRA, Adriana Alves
Contributors: TORRES, Natáli Valim Oliver Bento, http://lattes.cnpq.br/1927198788019996, orcid:0000-0003-0978-211X
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Diabetes mellitus tipo 1, Educação em saúde, Controle glicêmico, Exercícios físicos, Type 1 diabetes mellitus, Health education, Glycemic control, Physical exercises, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, PREVENÇÃO E QUALIDADE DE VIDA NO DIABETES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17112
-
20Dissertation/ Thesis
Authors: SOUZA, Laysa Lira de
Contributors: QUEIROZ, Natércia Neves Marques, http://lattes.cnpq.br/5359261920325026
Source: Disponível na internet via correio eletrônico: bibhujbb@ufpa.br
Subject Terms: Nutrição, Diabetes mellitus tipo 1, Controle glicêmico, Nutrition, Type 1 diabetes mellitus, Glycemic control, CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::ENDOCRINOLOGIA, DIAGNÓSTICO E TRATAMENTO DO DIABETES E SUAS COMPLICAÇÕES, DIABETES
File Description: application/pdf
Availability: https://repositorio.ufpa.br/jspui/handle/2011/17137